Clinical Trials Browser

OTHER × Genetic Testing × Gynecologic × Clear all

Carcinoma, Intraductal, Noninfiltrating, Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary, Hereditary Breast and Ovarian Cancer Syndrome

NCT03731845 2025-11-20

ESIGON

Phase NA Active not recruiting

73 enrolled

BreastGynecologic

Breast Neoplasms, Primary Ovarian Insufficiency

NCT05649072 2025-11-19

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Phase NA Recruiting

1,000 enrolled

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT03460483 2025-10-03

OPTEC

Phase NA Completed

1,001 enrolled

GastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms

NCT05591131 2025-02-21

GTM-I

Phase NA Active not recruiting

21 enrolled

Gynecologic

Ovarian Neoplasms, Endometrial Neoplasms

NCT03246841 2024-12-12

TUMOSPEC

Phase NA Active not recruiting

7,274 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT04067960 2024-08-14

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

Phase EARLY_PHASE1 Completed

197 enrolled

CNSGastrointestinalGenitourinaryGynecologic

Brain Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

NCT03322176 2019-01-23

Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing

Unknown

200 enrolled

GastrointestinalGynecologic

Colonic Neoplasms, Endometrial Neoplasms

NCT01850654 2018-06-28

OCCPI

Phase NA Completed

3,470 enrolled

GastrointestinalGynecologic

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT03338985 2018-01-05

Role of Senescence in the Development of Endometrial Cancer

Phase NA Unknown

140 enrolled

Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

Clinical Trials

Identifying and Caring for Individuals With Inherited Cancer Syndrome

ESIGON

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

OPTEC

GTM-I

TUMOSPEC

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing

OCCPI

Role of Senescence in the Development of Endometrial Cancer